Despite most of the research in iNKT cell-mediated killing activities against tumors have focused on cancer cell elimination, some studies have addressed the role of iNKT cell cytotoxicity in the control of the tumor microenvironment, especially of CD1d-positive, myeloid-derived cells. This evidence concerns the gene CD1D and cancer.